Gender differences in cardiac arrhythmias

Herz

Volumn 30, Issue 5, 2005, Pages 390-400

  Schulze Bahr, Eric ^a,b   Kirchhof, Paulus ^a,b,c   Eckardt, Lars ^a   Bertrand, Jessica ^b   Breithardt, Günter ^a,b,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c German Atrial Fibrillation Competence Network (AFNET)   (Germany)

Author keywords

Arrhythmias; Gender differences; Genes; Repolarization

Indexed keywords

ANTIARRHYTHMIC AGENT; ASTEMIZOLE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; HALOFANTRINE; ISOPRENALINE; PROPRANOLOL DERIVATIVE; QUINIDINE; SOLATOL; TERFENADINE; UNCLASSIFIED DRUG; VERAPAMIL;

ARRHYTHMOGENESIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRUGADA SYNDROME; CATHETER ABLATION; DEFIBRILLATOR; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART PROARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; QT INTERVAL; SEX DIFFERENCE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA;

ARRHYTHMIA; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TREATMENT OUTCOME;

EID: 24144497428     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2724-3     Document Type: Article

References (91)

1. Airaksinen KE, Ikaheimo MJ, Linnaluoto M, et al. Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion. J Am Coll Cardiol 1998;31:301-6.
2. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46.
3. Bailey MS, Curtis AB. The effects of hormones on arrhythmias in women. Curr Womens Health Rep 2002;2:83-8.
4. Bazett AM. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-69.
5. enjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
6. Borggrefe M, Budde T, Podczeck A, et al. High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 1987;10:576-82.
7. Burke JH, Ehlert FA, Kruse JT, et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997;79:178-81.
8. Burke JH, Goldberger JJ, Ehlert FA, et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996;100:537-43.
9. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
10. Conrath CE, Wilde AA, Jongbloed RJ, et al. Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. Cardiovasc Res 2002;53:770-6.
11. Coumel P. Polymorphous ventricular tachyarrhythmias in the absence of structural heart disease. Pacing Clin Electrophysiol 1997;20:2065-7.
12. Dagres N, Clague JR, Breithardt G, et al. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol 2003;42:1103-7.
13. Di Diego J, Cordeiro JM, Goodrow R, et al. Ionic and cellular basis for the predominance of the Brugada phenotype in males. Circulation 2002;106:21.
14. Ebert SN, Liu XK, Woosley RL. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health 1998;7:547-57.
15. Eckardt L, Haverkamp W, Borggrefe M, et al. Experimental models of torsade de pointes. Cardiovasc Res 1998;39:178-93.
16. Eckardt L, Haverkamp W, Mertens H, et al. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. J Cardiovasc Pharmacol 1998;32:425-34.
17. Eldar M, Pras E, Lahat H. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Cold Spring Harb Symp Quant Biol 2002;67:333-7.
18. Friberg J, Scharling H, Gadsboll N, et al. Sex-specific increase in the prevalence of atrial fibrillation (the Copenhagen City Heart Study). Am J Cardiol 2003;92:1419-23.
19. Friberg J, Scharling H, Gadsboll N, et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study). Am J Cardiol 2004;94:889-94.
20. Gleicher N, Meller J, Sandler RZ, et al. Wolff-Parkinson-White syndrome in pregnancy. Obstet Gynecol 1981;58:748-52.
21. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
22. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res 2000;47:219-33.
23. Herlitz J, Rundqvist S, Bang A, et al. Is there a difference between women and men in characteristics and outcome after in hospital cardiac arrest? Resuscitation 2001;49:15-23.
24. Hnatkova K, Waktare JE, Murgatroyd FD, et al. Age and gender influences on rate and duration of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1998;21:2455-8.
25. Horton HL, Marinchak RA, Rials SJ, et al. Gender differences in device therapy for malignant ventricular arrhythmias. Arch Intern Med 1995;155:2342-5.
26. Huikuri HV, Pikkujamsa SM, Airaksinen KE, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996;94:122-5.
27. Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005;20:26-30.
28. Kadish A. The effects of gender on cardiac electrophysiology and arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. Philadelphia: Saunders, 1995:1268-75.
29. Kadish AH, Greenland P, Limacher MC, et al. Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol 2004;9:366-374.
30. Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 1: Clinical features. Sleep 2002;25:412-9.
31. Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 2: Mechanisms. Sleep 2002;25:499-506.
32. Kirchhof P, Eckardt L, Franz MR, et al. Further evidence for prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome. Eur Heart J 2003;24:244.
33. Kottkamp H, Hindricks G, Autschbach R, et al. Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques. J Am Coll Cardiol 2002;40:475-80.
34. Krahn AD, Yee R, Klein GJ, et al. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol 1995;6:1124-8.
35. Kuch B, Hense HW, Sinnreich R, et al. Determinants of short-period heart rate variability in the general population. Cardiology 2001;95:131-8.
36. Kuo TB, Lin T, Yang CC, et al. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999;277:H2233-9.
37. Lahat H, Pras E, Olender T, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001;69:1378-84.
38. Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-90.
39. Lampert R, McPherson CA, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004;43:2293-9.
40. Larsen JA, Kadish AH. Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol 1998;9:655-64.
41. Lee RJ, Kalman JM, Fitzpatrick AP, et al. Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia. Circulation 1995;92:2919-28.
42. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.
43. Lehmann MH, Hardy S, Archibald D, et al. Sex differences in risk of torsade de pointes with d,l sotalol. Circulation 1996;94:2535-41.
44. Lehmann MH, Hardy S, Archibald D, et al. JTc prolongation with d,l-sotalol in women versus men. Am J Cardiol 1999;83:354-9.
45. Lehmann MH, Timothy KW, Frankovich D, et al. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol 1997;29:93-9.
46. Lerman BB, Dong B, Stein KM, et al. Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunit(alpha i2). J Clin Invest 1998;101:2862-8.
47. Lerman BB, Stein K, Engelstein ED, et al. Mechanism of repetitive monomorphic ventricular-tachycardia. Circulation 1995;92:421-9.
48. Lessmeier TJ, Gamperling D, Johnson-Liddon V, et al. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med 1997;157:537-43.
49. Liu K, Ballew C, Jacobs DR Jr, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension 1989;14:218-26.
50. Liu SW, Yuan SW, Kongstad O, et al. Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications. Scand Cardiovasc J 2001;35:313-7.
51. Liu XK, Katchman A, Drici MD, et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 1998;285:672-9.
52. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6.
53. Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998;97:2237-44.
54. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-7.
55. Martinez-Rubio A, Borggrefe M, Shenasa M, et al. Are there gender differences in patients with coronary artery disease presenting with spontaneous sustained ventricular tachycardia and ventricular fibrillation? Clin Cardiol 1995;18:161-6.
56. Merri M, Benhorin J, Alberti M, et al. Electrocardiographic quantitation of ventricular repolarization. Circulation 1989;80:1301-8.
57. Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999;340:534-44.
58. Myerburg RJ, Cox MM, Interian A Jr, et al. Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures. Am J Cardiol 1999;83:1049-54.
59. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43:2044-53.
60. Nakagawa M, Ooie T, Ou B, et al. Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 2005;16:278-84.
61. Natale A, Newby KH, Pisano E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000;35:1898-904.
62. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001;104:2539-44.
63. Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42:185-97.
64. Perers E, Abrahamsson P, Bang A, et al. There is a difference in characteristics and outcome between women and men who suffer out of hospital cardiac arrest. Resuscitation 1999;40:133-40.
65. Peters RW, Gold MR. The influence of gender on arrhythmias. Cardiol Rev 2004;12:97-105.
66. Pham TV, Rosen MR. Sex, hormones, and repolarization. Cardiovasc Res 2002;53:740-51.
67. Pires LA, Sethuraman B, Guduguntla VD, et al. Outcome of women versus men with ventricular tachyarrhythmias treated with the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2002;13:563-8.
68. Porter MJ, Morton JB, Denman R, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004;1:393-6.
69. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74.
70. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200.
71. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-74.
72. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992;8:690-5.
73. Rodriguez I, Kilborn MJ, Liu XK, et al. Drug-induced QT prolongation in women during the menstrual cycle. JAMA 2001;285:1322-6.
74. Russo AM, Stamato NJ, Lehmann MH, et al. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004;15:993-8.
75. Saba S, Link MS, Homoud MK, et al. Effect of low estrogen states in healthy women on dispersion of ventricular repolarization. Am J Cardiol 2001;87:354-6,A9-10.
76. Saba S, Zhu W, Aronovitz MJ, et al. Effects of estrogen on cardiac electrophysiology in female mice. J Cardiovasc Electrophysiol 2002;13:276-80.
77. Schulze-Bahr E, Eckardt L, Breithardt G, et al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 2003;21:651-2.
78. Smetana P, Batchvarov V, Hnatkova K, et al. Sex differences in the rate dependence of the T wave descending limb. Cardiovasc Res 2003;58:549-54.
79. Stramba-Badiale M, Locati EH, Martinelli A, et al. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 1997;18:1000-6.
80. Suttorp MJ, Kingma JH, Koomen EM, et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993;71:710-3.
81. Tawam M, Levine J, Mendelson M, et al. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993;72:838-40.
82. Tran H, White CM, Chow MS, et al. An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann Noninvasive Electrocardiol 2001;6:129-33.
83. Vatta M, Dumaine R, Varghese G, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002;11:337-45.
84. Villareal RP, Woodruff AL, Massumi A. Gender and cardiac arrhythmias. Tex Heart Inst J 2001;28:265-75.
85. Viskin S. Inducible ventricular fibrillation in the Brugada syndrome: diagnostic and prognostic implications. J Cardiovasc Electrophysiol 2003;14:458-60.
86. Viskin S, Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy. Prog Cardiovasc Dis 1998;41:17-34.
87. Wachtell K, Hornestam B, Lehto M, et al. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005;45:705-11.
88. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines: new challenges of the old problem. Arch Intern Med 2004;164:2126-34.
89. Yap YG, Duong T, Bland M, et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 2005;26:1385-93.
90. Zareba W, Moss AJ, Locati EH, et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 2003;42:103-9.
91. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960-5.